Skip to content
NBlaz – Lifestyle
Author:
Elicio Therapeutics Inc.
Elicio Therapeutics Announces Publication in Peer-Reviewed Journal Science Advances Highlighting Potent and Durable Immune Responses Driven by Company’s AMP-DNA Adjuvant Technology
June 1, 2026
Elicio Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updates
May 11, 2026
Elicio Therapeutics to Present at the Bank of America Healthcare Conference
April 30, 2026
←
Previous Page
1
2